trending Market Intelligence /marketintelligence/en/news-insights/trending/hms0ctnf7j8cdsmxw7q99w2 content esgSubNav
In This List

China Resources Pharmaceutical director resigns

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


China Resources Pharmaceutical director resigns

Wang Jing resigned as a nonexecutive director of China Resources Pharmaceutical Group Ltd. due to other work commitments.

Wang is the CFO of Beijing State-Owned Capital Operations and Management Center, or BSCOMC, an investment and asset management firm focused on China. BSCOMC is also an investor in China Resources, according to S&P Capital IQ data.

Concurrently, China Resources appointed Wang Shouye and Lu Ruizhi to its board as nonexecutive directors.

Lu is BSCOMC's general manager of the investment management second division.

Hong Kong-based China Resources is an investment holding company involved in the development and distribution of pharmaceutical and healthcare products in China and Hong Kong.